Impurity and variant characterization
Assess your GLP-1 product for purity, and critical quality attributes. Impurities can affect safety, efficacy and immunogenicity. When submitting GLP-1 peptides its important to understand and monitor process impurities from synthesis or manufacturing. Product‑related variants such as oxidation, deamidation, truncations and aggregation must be identified and quantified, including low‑level species.
Share:
Got Questions?
Got Questions?
Fill out the information below, then click Next to download the guide.
By filling out the form, you are agreeing to our Terms of Use and understand that the information you have provided on this website will be used and processed by Waters in accordance with the Waters Privacy Notice.